Firm founder and Managing Partner Dave Rodman speaks about FDA regulation of cannabinoids in general, and CBD in particular, at the 2019 Medical Cannabiz Summit in Malta
The information in this blog post (the "Blog" or "Post") is provided as news and/or commentary for general informational purposes only. The information herein does not, and shall never, constitute legal advice and therefore cannot be relied upon as a legal opinion. Nothing in this Blog constitutes attorney communication and is not privileged information. Nothing in the Post or on this website creates any kind of attorney client relationship or privilege of any kind.